Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 4Thoracic 1Gynecologic 1Gastrointestinal 1

Conditions

Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Thymoma 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Pancreatic Neoplasms 1Mesothelioma, Malignant 1Mesothelioma 1Liver Neoplasms 1Kidney Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

talazoparib 1Nivolumab 1Imatinib Mesylate 1FANG vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × FANG vaccine × Thoracic × Clear all
NCT01061840 2022-03-15

Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer

Gradalis, Inc.

Phase 1 Completed
100 enrolled
GastrointestinalSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Liver Neoplasms, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡